NKX3.1 by Immunohistochemistry
Also known as: NKX3.1 IHC
Use
Immunohistochemical detection of the NKX3.1 protein, a nuclear tumor suppressor gene product, used primarily as a stain-and-return technical service. This assay is intended for clinical purposes and performed in a CLIA-certified laboratory, serving in diagnostic evaluation of tissue specimens to characterize NKX3.1 expression in tumors.
Special Instructions
This test is a stain-and-return (technical) service only. It is performed as a Laboratory Developed Test (LDT) by ARUP Laboratories. Ordering recommendations and interface mapping refer to the ARUP Immunohistochemistry Stain Offerings brochure. The test is New York state approved.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration. Interpretation is limited to the technical stain; pathologist interpretation is not included. As a technical service only, results are limited to stain performance and not diagnostic conclusions.
New York Approved
Methodology
Immunoassay (IHC)
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
tissue transport kit or unstained slides
Collection Instructions
Transport tissue block or 5 unstained (3‑ to 5‑micron thick) positively charged slides (min: 2 slides). Do not oven bake precut slides.
Storage Instructions
Room temperature acceptable; refrigerated acceptable; ship in cooled container during summer months.
Causes for Rejection
Non‑representative tissue type; depleted specimens
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Indefinitely |
| Refrigerated | Indefinitely |
| Frozen | Unacceptable |